Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04088032
Title Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer
Recruitment Withdrawn
Gender female
Phase Phase I
Variant Requirements No
Sponsors Alison Stopeck
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.